TCM Biotech International Corp. Stock

TCM BIOTECH INTERNATIONAL CORP. is a Taiwan-based company principally engaged in the detection and development of new medicine for liver disease. The Company's main businesses include the development of new medicine, which are mainly used for the treatment of hepatitis C and non-alcoholic fatty liver and other disease, manufacture and sales of dietary supplements and botanical raw materials, the sales of western medicine products and medical equipment, which are mainly used for the treatment of orthopedic disorders, cardiovascular disorders, oncology disorders and others, sales agent of organic products. The Company distributes its products both in domestic markets and to overseas markets.